2025 third_quarter Filing
Q3Lobbying Activities (4)
Health Issues
View allIssues related to compounding and counterfeit drugs.
Medicare/Medicaid
View allIssues related to drug pricing and implementation of the Inflation Reduction Act.
H.R. 1492, the Ensuring Pathways to Innovative Cures Act. Issues related to coverage of anti-obesity medications.
H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to drug pricing and pharmacy benefit management reforms. Issues related to Most Favored Nation drug pricing.
Taxation/Internal Revenue Code
View allH.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes and foreign-based multinationals.
H.R. 591, Defending American Jobs and Investment Act, and H.R. 2423, Unfair Tax Prevention Act, as they relate to multinational corporations.
Trade (domestic/foreign)
View allIssues related to tariffs. Issues related to importation of counterfeit drugs.